Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
LeonaBio, Inc.
LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit
June 4, 2026
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
May 31, 2026
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
May 29, 2026
LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
May 28, 2026
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
May 26, 2026
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data
May 25, 2026
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
February 3, 2026